Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV

By sjmartinez • January 2, 2025

Fairlie L, Brummel S, Ziemba L, Coletti A, Chinula L, Shapiro R, Stringer J, Malonga G, Browning R, Chakhtoura N, Mmbaga BT, Mhembere TP, Omoz-Oarhe A, Nagaddya B, Naidoo M, Hoffman RM, Lockman S; IMPAACT 2010/VESTED Study Team. Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV. J Acquir Immune Defic Syndr. 2024 Oct;97(2):150-155. doi: 10.1097/qai.0000000000003473. PMID: 39742354; PMCID: PMC11684739.

Tags: Conception on antiretroviral therapy, high rates adverse outcomes, Infectious Diseases, interpregnancy interval, pregnancy outcomes, prior pregnancy loss, Publications, Women living with HIV

Opioid agonist therapy adherence trajectories among commercially and publicly insured people living with Hepatitis C in the United States

Psaras C, Arah OA, Chew KW, Lee SJ, Javanbakht M, Nianogo RA, Seamans MJ. Opioid agonist therapy adherence trajectories among commercially and publicly insured people[...]

Miltefosine Failure and Amphotericin B Success in the Treatment of a Case of Cutaneous Leishmania Braziliensis in a Recent Traveler in Belize and Guatemala

Ko MY, Fowler E, Scott A, Uslan DZ. Miltefosine Failure and Amphotericin B Success in the Treatment of a Case of Cutaneous Leishmania Braziliensis in a Recent[...]

Libraries Burned, a Life Lived

Vijayan T. Libraries Burned, a Life Lived. N Engl J Med. 2025 Jul 5. doi: 10.1056/NEJMp2500746. Epub ahead of print. PMID: 40621845.